These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35723850)
1. Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial. Vazirian F; Samadi S; Abbaspour M; Taleb A; Bagherhosseini H; Mozaffari HM; Mohammadpour AH; Emami SA Inflammopharmacology; 2022 Dec; 30(6):2145-2152. PubMed ID: 35723850 [TBL] [Abstract][Full Text] [Related]
2. Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial. Mules TC; Lavender B; Maclean K; Vacca F; Noble SL; Yumnam B; Te Kawa T; Cait A; Tang J; O'Sullivan D; Gasser O; Stanley J; Le Gros G; Camberis M; Inns S Inflamm Bowel Dis; 2024 May; 30(5):735-745. PubMed ID: 37318363 [TBL] [Abstract][Full Text] [Related]
3. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial. Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157 [TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis. Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271 [TBL] [Abstract][Full Text] [Related]
5. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700 [TBL] [Abstract][Full Text] [Related]
6. Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial. Ben-Horin S; Salomon N; Karampekos G; Viazis N; Lahat A; Ungar B; Eliakim R; Kuperstein R; Kriger-Sharabi O; Reiss-Mintz H; Yanai H; Dotan I; Zittan E; Maharshak N; Hirsch A; Weitman M; Mantzaris GJ; Kopylov U Clin Gastroenterol Hepatol; 2024 Feb; 22(2):347-356.e6. PubMed ID: 37302449 [TBL] [Abstract][Full Text] [Related]
7. A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis. Fiorino G; Sturniolo GC; Bossa F; Cassinotti A; di Sabatino A; Giuffrida P; Danese S Cells; 2019 May; 8(6):. PubMed ID: 31151306 [TBL] [Abstract][Full Text] [Related]
8. Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled Trial. Kedia S; Virmani S; Bajaj A; Markandey M; Singh N; Madan D; Kaushal K; Sahu P; Vuyyuru SK; Kante B; Kumar P; Thomas DM; Mundhra SK; Singh MK; Verma M; Sharma R; Das P; Dash NR; Monga N; Awasthi A; Makharia G; Ahuja V Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1295-1306.e7. PubMed ID: 38278200 [TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study. Langhorst J; Varnhagen I; Schneider SB; Albrecht U; Rueffer A; Stange R; Michalsen A; Dobos GJ Aliment Pharmacol Ther; 2013 Sep; 38(5):490-500. PubMed ID: 23826890 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial. Masoodi M; Mahdiabadi MA; Mokhtare M; Agah S; Kashani AHF; Rezadoost AM; Sabzikarian M; Talebi A; Sahebkar A J Cell Biochem; 2018 Nov; 119(11):9552-9559. PubMed ID: 30132960 [TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Bjarnason I; Sission G; Hayee B Inflammopharmacology; 2019 Jun; 27(3):465-473. PubMed ID: 31054010 [TBL] [Abstract][Full Text] [Related]
12. Oral Fluconazole Therapy in Patients With Active Ulcerative Colitis Who Have Detectable Candida in the Stool : A Double-Blind Randomized Placebo-controlled Trial. Jena A; Dutta U; Shah J; Sharma V; Prasad KK; Shivaprakash RM; Mandavdhare HS; Samanta J; Sharma P; Popli P; Sharma AK; Sinha SK; Chakrabarti A; Kochhar R J Clin Gastroenterol; 2022 Sep; 56(8):705-711. PubMed ID: 34516459 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study. Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045 [TBL] [Abstract][Full Text] [Related]
15. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Pedersen N; Thielsen P; Martinsen L; Bennedsen M; Haaber A; Langholz E; Végh Z; Duricova D; Jess T; Bell S; Burisch J; Munkholm P Inflamm Bowel Dis; 2014 Dec; 20(12):2276-85. PubMed ID: 25248002 [TBL] [Abstract][Full Text] [Related]
16. Curcumin for maintenance of remission in ulcerative colitis. Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial. Amiri M; Navabi J; Shokoohinia Y; Heydarpour F; Bahrami G; Behbood L; Derakhshandeh P; Momtaz S; Farzaei MH Complement Ther Med; 2019 Aug; 45():262-268. PubMed ID: 31331572 [TBL] [Abstract][Full Text] [Related]
18. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Feagan BG; Sandborn WJ; D'Haens G; Pola S; McDonald JWD; Rutgeerts P; Munkholm P; Mittmann U; King D; Wong CJ; Zou G; Donner A; Shackelton LM; Gilgen D; Nelson S; Vandervoort MK; Fahmy M; Loftus EV; Panaccione R; Travis SP; Van Assche GA; Vermeire S; Levesque BG Gastroenterology; 2013 Jul; 145(1):149-157.e2. PubMed ID: 23528626 [TBL] [Abstract][Full Text] [Related]
19. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Vernia P; Monteleone G; Grandinetti G; Villotti G; Di Giulio E; Frieri G; Marcheggiano A; Pallone F; Caprilli R; Torsoli A Dig Dis Sci; 2000 May; 45(5):976-81. PubMed ID: 10795763 [TBL] [Abstract][Full Text] [Related]
20. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study. Sun J; Yuan Y Adv Ther; 2016 Mar; 33(3):400-9. PubMed ID: 26898569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]